IMCAS's COVID-19 vaccine obtains emergency use approval in China

A COVID-19 vaccine developed by the Institute of Microbiology of Chinese Academy of Sciences (IMCAS) has obtained the greenlight for emergency use in China, the institute said on Monday.

Source(s): Reuters